In an 85-year-old female with a history of hypertension and moderate tricuspid regurgitation who is currently taking metoprolol succinate (Toprol-XL) 25 mg daily, but now has rising blood pressure (140–160 mm Hg systolic, 90–100 mm Hg diastolic) and tachycardia (heart rate 110–120 bpm) despite unchanged diet, sleep, and activity, what is the appropriate management?

Management of Rising Blood Pressure and Tachycardia in an 85-Year-Old on Low-Dose Beta-Blocker

This patient requires immediate investigation for medication non-adherence, drug interactions, or secondary causes of hypertension before adjusting therapy, followed by uptitration of her current metoprolol succinate and addition of a second antihypertensive agent if needed.

Immediate Assessment Priorities

The sudden deterioration in blood pressure control (now 140-160/90-100 mmHg) with paradoxical tachycardia (110-120 bpm) despite being on a beta-blocker is highly concerning and suggests:

Critical Differential Considerations

1. Medication non-adherence - Most common cause of sudden BP loss of control
2. Drug interactions - Specifically check for:
   • CYP2D6 inhibitors (fluoxetine, paroxetine, quinidine, propafenone) which can paradoxically reduce metoprolol's effectiveness by altering metabolism 1
   • NSAIDs, decongestants, or other over-the-counter medications
3. New atrial fibrillation - Given her moderate tricuspid regurgitation and tachycardia, obtain an ECG immediately
4. Volume overload - Assess for worsening tricuspid regurgitation with right heart failure 2, 3
5. Secondary hypertension - Though less likely with sudden onset, consider if other causes excluded 4

Diagnostic Workup

Before adjusting medications, obtain:

• ECG - Rule out atrial fibrillation or other arrhythmias causing tachycardia
• Medication reconciliation - Verify she's actually taking the Toprol-XL and check for new medications
• Echocardiogram - Assess if tricuspid regurgitation has worsened (severe TR can cause tachycardia and volume overload) 5, 6
• Basic metabolic panel - Check renal function and electrolytes
• Home blood pressure log review - Confirm office readings reflect true hypertension, not white coat effect

Pharmacological Management Algorithm

Step 1: Optimize Current Beta-Blocker Therapy

Increase metoprolol succinate from 25 mg to 50-100 mg daily 1. The current dose of 25 mg is subtherapeutic for most patients. According to FDA labeling, the usual initial dose is 25-100 mg daily, with adjustments at weekly intervals up to 400 mg/day if needed 1. Her heart rate of 110-120 bpm indicates inadequate beta-blockade.

Step 2: Add Combination Therapy

Given her age (85 years) and moderate tricuspid regurgitation, add a dihydropyridine calcium channel blocker (CCB) OR a thiazide-like diuretic as second-line therapy 7.

Preferred approach:

• Amlodipine 2.5-5 mg daily - Start low in elderly patients 7
• OR Chlorthalidone 12.5 mg daily - Thiazide-like diuretics are preferred over thiazides 7

The 2024 ESC guidelines specifically recommend combination therapy for most patients with confirmed hypertension (BP ≥140/90 mmHg), with preferred combinations being a RAS blocker with either a CCB or diuretic 7. However, in patients aged ≥85 years, slower uptitration and lower dosing should be considered 7.

Step 3: Consider ACE Inhibitor or ARB Addition

If BP remains uncontrolled after optimizing beta-blocker and adding CCB/diuretic, add an ACE inhibitor (lisinopril 2.5-5 mg daily) or ARB (losartan 25-50 mg daily) 7, 8. This creates a three-drug combination (beta-blocker + CCB + RAS blocker or beta-blocker + diuretic + RAS blocker).

Special Considerations for This Patient

Age-Related Factors (85 Years Old)

• Target BP: 130-139/70-79 mmHg - Avoid overly aggressive lowering in very elderly patients 7
• Monitor for orthostatic hypotension - Check standing BP at each visit
• Assess for frailty - If moderate-to-severe frailty present, use slower uptitration 7
• Start all new medications at lower doses and titrate slowly

Tricuspid Regurgitation Considerations

Her moderate tricuspid regurgitation requires specific attention:

• Diuretics may be beneficial if there's evidence of volume overload or right heart failure 3, 5
• However, avoid excessive diuresis - Daily loop diuretic doses ≥40 mg furosemide equivalent are associated with increased mortality in TR patients 2
• Optimize afterload reduction - ACE inhibitors or ARBs may help reduce TR severity by improving hemodynamics 3
• Beta-blockers are appropriate for rate control if atrial fibrillation develops, which is common with TR 5

Monitoring the Tachycardia

The heart rate of 110-120 bpm is particularly concerning:

1. If sinus tachycardia - Suggests inadequate beta-blockade; increase metoprolol dose
2. If atrial fibrillation - Beta-blocker remains appropriate for rate control 7, but may need higher doses or additional rate-controlling agents
3. If related to volume overload from TR - Consider adding low-dose diuretic therapy 3

Common Pitfalls to Avoid

1. Don't assume the current medication is working - Verify adherence first
2. Don't add multiple medications simultaneously in elderly patients - Titrate one at a time
3. Don't use non-dihydropyridine CCBs (diltiazem, verapamil) - These can cause excessive bradycardia when combined with beta-blockers 1
4. Don't combine ACE inhibitor with ARB - This increases cardiovascular and renal risk 8
5. Don't ignore the tachycardia - This suggests either non-adherence, inadequate dosing, or a new arrhythmia requiring investigation

Follow-Up Timeline

• Week 1-2: Verify medication adherence, obtain ECG and labs
• Week 2-4: Increase metoprolol to 50-100 mg daily if adherent
• Week 4-8: Add second agent (CCB or diuretic) if BP not controlled
• Week 8-12: Reassess; add third agent if needed
• Target: Achieve BP control within 3 months 7

The key is systematic evaluation before assuming treatment failure, then methodical uptitration of existing therapy before adding new agents, while being mindful of her advanced age and cardiac comorbidity.